Screening for Potential Antiviral Compounds from Cyanobacterial Secondary Metabolites Using Machine Learning
Marine Drugs · 05.11.2024 · 22 (11) · 501
DOI: 10.3390/md22110501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 05.11.2024. Verfasst von Tingrui Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Marine Ecology and Human Factors Assessment Technical Innovation Center of Natural Resources Ministry, Tsinghua Shenzhen International Graduate Schoo…. Hauptthemen laut MEDLINE: Cyanobacteria, Machine Learning, Molecular Docking Simulation, Antiviral Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the NSFC, the Shenzhen Science and Technology Program, the Innovation Team Project for Guangdong's Universities.
Abstract (Originalsprache)
The secondary metabolites of seawater and freshwater blue-green algae are a rich natural product pool containing diverse compounds with various functions, including antiviral compounds; however, high-efficiency methods to screen such compounds are lacking. Advanced virtual screening techniques can significantly reduce the time and cost of novel antiviral drug identification. In this study, we used a cyanobacterial secondary metabolite library as an example and trained three models to identify compounds with potential antiviral activity using a machine learning method based on message-passing neural networks. Using this method, 364 potential antiviral compounds were screened from >2000 cyanobacterial secondary metabolites, with amides predominating (area under the receiver operating characteristic curve value: 0.98). To verify the actual effectiveness of the candidate antiviral compounds, HIV virus reverse transcriptase (HIV-1 RT) was selected as a target to evaluate their antiviral potential. Molecular docking experiments demonstrated that candidate compounds, including kororamide, mollamide E, nostopeptolide A3, anachelin-H, and kasumigamide, produced relatively robust non-covalent bonding interactions with the RNase H active site on HIV-1 RT, supporting the effectiveness of the proposed screening model. Our data demonstrate that artificial intelligence-based screening methods are effective tools for mining potential antiviral compounds, which can facilitate the exploration of various natural product libraries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marine Ecology and Human Factors Assessment Technical Innovation Center of Natural Resources Ministry, Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.
- Shenzhen Public Platform for Screening and Application of Marine Microbial Resources, Institute for Ocean Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Shenzhen Key Laboratory of Advanced Technology for Marine Ecology, Institute for Ocean Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Institute for Ocean Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
ORCID-Profile: Jin Zhou
Förderung
- the NSFC
- the Shenzhen Science and Technology Program
- the Innovation Team Project for Guangdong's Universities
- NSFC
- Shenzhen Science and Technology Program
Zitieren
APA
Zhang, T., Sun, G., Cheng, X., Cao, C., Cai, Z., & Zhou, J. (2024). Screening for Potential Antiviral Compounds from Cyanobacterial Secondary Metabolites Using Machine Learning. Marine Drugs, 22(11), 501. https://doi.org/10.3390/md22110501
Vancouver
Zhang T, Sun G, Cheng X, Cao C, Cai Z, Zhou J. Screening for Potential Antiviral Compounds from Cyanobacterial Secondary Metabolites Using Machine Learning. Marine Drugs. 2024;22(11):501. doi:10.3390/md22110501
BibTeX
@article{Zhang2024,
author = {Zhang, Tingrui and Sun, Geyao and Cheng, Xueyu and Cao, Cheng and Cai, Zhonghua and Zhou, Jin},
title = {Screening for Potential Antiviral Compounds from Cyanobacterial Secondary Metabolites Using Machine Learning},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {11},
pages = {501},
doi = {10.3390/md22110501}
}
EUVIMED